New hope for tough prostate cancer: experimental drug AB-3028 enters human trials
Disease control
Recruiting now
This study tests a new drug, AB-3028, in people with a type of advanced prostate cancer that has stopped responding to standard hormone treatments. About 190 participants will receive the drug to see if it is safe and can shrink tumors or slow the disease. The goal is to find the…
Phase: PHASE1, PHASE2 • Sponsor: Arsenal Biosciences, Inc. • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC